期刊文献+

SYNTAX积分预测冠心病复杂病变患者经皮冠状动脉介入治疗预后的作用 被引量:1

Role of SYNTAX score in predicting prognosis of patients with complex coronary heart disease after percutaneous coronary intervention
下载PDF
导出
摘要 目的评价SYNTAX积分对冠心病3支病变和(或)左主干病变患者PCI预后的作用。方法经冠状动脉造影证实的3支病变和(或)左主干病变并接受PCI的患者1 90例。对每例患者造影结果进行SYNTAX评分,SYNTAX评分按三分位数分为:低分组、中分组和高分组,通过门诊或电话随访患者主要不良心脑血管事件(MACCE)。结果经PCI的冠心病3支病变和(或)左主干病变190例患者中,29例出现MACCE,发生率为15.3%。SYNTAX积分低分组、中分组及高分组的MACCE发生率分别为9.1%、1 6.2%及30.9%。Cox多因素分析显示,SYNTAX积分HR=2.07,95%CI:1.25~3.44,差异有统计学意义(P=0.005)。结论 SYNTAX积分是预测PCI预后的较理想工具,该积分系统也适用于我国冠心病3支病变和(或)左主干病变患者PCI术后预后的预测。 Objective To assess the role of SYNTAX score in predicting the prognosis of patients with triple vessel lesion and/or left main coronary artery lesion after percutaneous coronary intervention(PCI). Methods One hundred and ninety patients with coronary arteriography-confirmed triple vessel lesion and/or left' main coronary artery lesion after PCI were scored with the SYNTAX scoring system according to their coronary arteriographic findings. The patients were followed up by telephone or at outpatient department to find their major adverse cardiocerebral events(MACCE). Results Among the 190 patients, MACCE occurred in 29, accounting for 15.3%. Multivariate Cox regression analysis showed that the incidence of MACCE was 9. 1%, 16.2% and 30.9%, respectively, in patients with a low, moderate, and high SYNTAX score (HR=2.07,95%CI.1.25-3.44,P=0. 005). Conclusion SYNTAX score can predict the prognosis of patients with triple vessel lesion and/or left main coronary artery lesion after PCI.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2012年第6期596-599,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 冠心病 药物洗脱支架 冠状动脉疾病 冠状血管造影术 预后 预测 coronary disease drug-eluting stents coronary artery disease coronary angiography prognosis forecasting
  • 相关文献

参考文献1

二级参考文献20

  • 1Ryan TJ, Faxon DE Gunnar RM, Kennedy JW, King SB, Loop FD, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American college of cardiology/American heart association task force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee on percutaneous transluminal coronary angioplasty). Circulation 1988; 78: 486-502.
  • 2Ellis SG, Vandormael MG, Cowley MJ, Whitlow PL, Schneider JP, Topol EJ. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 1990; 82:1193-1202.
  • 3Hamburger JN, Serruys PW, Scabra-Gomes R, Simon R, Koolen J J, Fleck E, et al. Recanalization of total coronary occlusions using a laser guidewire (the European TOTAL Surveillance Study). Am J Cardiol 1997; 80: 1419-1423.
  • 4Iwakura K, Ito H, Ikushima M, Okamura A, Asano K, Kuroda T, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003; 41: 1-7.
  • 5Lefevre T, Louvard Y, Morice MC, Dumas P, Loubeyre C, Benslimane A, et al. Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv 2000; 49: 274-283.
  • 6Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
  • 7Gyongyosi M, Christ G, Lang I, Kreiner G, Sochor H, Probst E et al. Two-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy.between percutaneous coronary intervention with TAXUS and cardiac surgery) study. JACC Cardiovasc Interv 2009; 2: 718-727.
  • 8Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern M J, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation 2001; 103: 3019-3041.
  • 9Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schomig A, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007; 370: 937-948.
  • 10Kirtane A J, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, et al. Safety and efficacy of drug-elating and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009; 119: 3198-3206.

共引文献17

同被引文献12

  • 1芮浩淼,齐超,吴长燕.冠脉造影SYNTAX积分对老年冠心病患者经皮冠状动脉介入治疗预后的预测作用[J].中国老年学杂志,2014,34(1):85-86. 被引量:11
  • 2CETINKAL G, DOGAN S M, KOCAS C, et al. The value of the Clinical SYNTAX Score in predicting long-term prognosis in patients with ST-segment elevation myocardial infarction who have undergone primary percutaneous coronary intervention [ J ]. Coron Artery Dis, 2016, 27(2) : 135-142.
  • 3NAGASHIMA Y, IIJIMA R, NAKAMURA M, et al. Utility of the SYNTAX score in predicting outcomes after coronary intervention for chronic total occlusion [J]. Herz, 2015, 40 (8) : 1090-1096.
  • 4SAFARIAN H, ALIDOOSTI M, SHAFIEE A, et al. The SYNTAX score can predict major adverse cardiac events following percutaneous coronary intervention [J]. Heart Views, 2014, 15(4) : 99-105.
  • 5RODRIGUEZ A E, FERNANDEZ-PEREIRA C, MIERES J, et al. Modifying angiographic syntax score according to PCI strategy: lessons learnt from ERACI IV Study [J]. Cardiovasc Revasc Med, 2015, 16(7) : 418-420.
  • 6CAMPOS C M, STANETIC B M, FAROOQ V, et al. Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial [J]. Catheter Cardiovasc Interv, 2015, 86 (6) : E229- E238.
  • 7CAMPOS C M, GARCIA-GARCIA H M, VAN KLAVEREN D, et al. Validity of SYNTAX score II for risk stratification of percutaneous coronary interventions: A patient-level pooled analysis of 5,433 patients enrolled in contemporary coronary stent trials[J]. Int J Cardiol, 2015, 187(2) : 111-115.
  • 8高阅春,玉献鹏,何继强,陈方.SYNTAX积分对冠心病经皮冠状动脉介入治疗效果的预测[J].中华内科杂志,2012,51(1):31-33. 被引量:13
  • 9高阅春,玉献鹏,何继强,吴长燕,张晓玲,李宇,罗亚玮,张宇晨,张维东,陈方.不同分层标准SYNTAX积分对经皮冠状动脉介入治疗复杂冠心病患者的预测价值[J].中国全科医学,2012,15(5):512-515. 被引量:7
  • 10张宇晨,赵林,玉献鹏,陈方,张晓玲,高阅春,何继强.临床SYNTAX积分预测行经皮冠状动脉介入治疗复杂冠心病患者预后作用的研究[J].中国全科医学,2012,15(12):1342-1345. 被引量:1

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部